Leonid Capital Partners — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Anivive Lifesciencesanivive.comin𝕏Jul 2021 · $20M
Anivive develops new medicines for companion animals, using software across the drug development process to accelerate the creation of treatments.
AI & Machine LearningBiotechDeep TechHealthtechLong Beach, US
Dylan Balsz(Executive Officer, Director)inDavid Bruyette(Chief Medical Officer)inRobert Bishop(Director)Lynne Doti(Director)Cheryl Collett(Executive Officer)Glenn Stearns(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.